Basic fibroblast growth factor released from fucoidan-modified chitosan/alginate scaffolds for promoting fibroblasts migration

  • Huang-Yu Zeng
  • Yi-Cheng Huang


Wound repair process is initiated immediately after injury by releasing a variety of growth factors. It is known that basic fibroblast growth factor (bFGF) promoted fibroblasts migration, proliferation and effective helped skin wound healing. However, the use of bFGF is limited by two drawbacks, which are its short half-life and easily degraded by enzymes. In this study, we fabricate fucoidan-modified chitosan/alginate (F-CS/Alg) scaffold to protect and control release bFGF to regulate fibroblast migration activity. The experimental results show that oversulfated fucoidan was successfully prepared, with 43% sulfation degree. The 43% sulfated fucoidan (F43) exhibited effective DPPH scavenging activity, good biocompatibility and protected bFGF from trypsin degradation. The F43-CS/Alg scaffold could maintain bFGF activity and control its release, reaching 2.52 ng/mL for 10 h releasing. In vitro cell studies demonstrate that F43-CS/Alg scaffold showed a considerable elevation in cell viability and promoted L929 fibroblasts migration efficiently. In brief, bFGF loaded F43-CS/Alg scaffold effectively accelerating fibroblast migration for wound repair and could have a great potential in clinical applications in the future.


Basic fibroblast growth factor Fucoidan Chitosan Sulfation degree Fibroblast migration 



The authors would like to thank the National Science Council of the Republic of China, Taiwan for financially supporting this research under Contract No. MOST 104-2221-E-017-MY3. Thanks to Ms. C.Y. Chien of Ministry of Science and Technology for the assistance in SEM experiments. Wallace Academic Editing is appreciated for editorial assistance.

Supplementary material

10965_2018_1476_Fig8_ESM.gif (15 kb)

(GIF 14 kb)

10965_2018_1476_MOESM1_ESM.tif (316 kb)
High resolution image (TIFF 316 kb)


  1. 1.
    Werner S, Grose R (2003) Regulation of wound healing by growth factors and cytokines. Physiol Rev 83(3):835–870. CrossRefGoogle Scholar
  2. 2.
    Martin P (1997) Wound healing--aiming for perfect skin regeneration. Science 276(5309):75–81CrossRefGoogle Scholar
  3. 3.
    Freedberg IM, Tomic-Canic M, Komine M, Blumenberg M (2001) Keratins and the keratinocyte activation cycle. J Invest Dermatol 116(5):633–640. CrossRefGoogle Scholar
  4. 4.
    Hantash BM, Zhao L, Knowles JA, Lorenz HP (2008) Adult and fetal wound healing. Front Biosci 13:51–61CrossRefGoogle Scholar
  5. 5.
    Raja SK, Garcia MS, Isseroff RR (2007) Wound re-epithelialization: modulating keratinocyte migration in wound healing. Front Biosci 12:2849–2868CrossRefGoogle Scholar
  6. 6.
    N. Scott Adzick MD (1997) The molecular and cellular biology of wound repair, 2nd edn. Academic Press, LondonGoogle Scholar
  7. 7.
    Grayson LS, Hansbrough JF, Zapata-Sirvent RL, Dore CA, Morgan JL, Nicolson MA (1993) Quantitation of cytokine levels in skin graft donor site wound fluid. Burns 19(5):401–405CrossRefGoogle Scholar
  8. 8.
    Edmonds M, Bates M, Doxford M, Gough A, Foster A (2000) New treatments in ulcer healing and wound infection. Diabetes Metab Res Rev 16(Suppl 1):S51–S54CrossRefGoogle Scholar
  9. 9.
    Harris IR, Yee KC, Walters CE, Cunliffe WJ, Kearney JN, Wood EJ, Ingham E (1995) Cytokine and protease levels in healing and non-healing chronic venous leg ulcers. Exp Dermatol 4(6):342–349CrossRefGoogle Scholar
  10. 10.
    Shankaran V, Brooks M, Mostow E (2013) Advanced therapies for chronic wounds: NPWT, engineered skin, growth factors, extracellular matrices. Dermatol Ther 26(3):215–221. CrossRefGoogle Scholar
  11. 11.
    DiGabriele AD, Lax I, Chen DI, Svahn CM, Jaye M, Schlessinger J, Hendrickson WA (1998) Structure of a heparin-linked biologically active dimer of fibroblast growth factor. Nature 393(6687):812–817. CrossRefGoogle Scholar
  12. 12.
    Sperinde GV, Nugent MA (1998) Heparan sulfate proteoglycans control intracellular processing of bFGF in vascular smooth muscle cells. Biochemistry 37(38):13153–13164. CrossRefGoogle Scholar
  13. 13.
    Pieper JS, Hafmans T, van Wachem PB, van Luyn MJ, Brouwer LA, Veerkamp JH, van Kuppevelt TH (2002) Loading of collagen-heparan sulfate matrices with bFGF promotes angiogenesis and tissue generation in rats. J Biomed Mater Res 62(2):185–194. CrossRefGoogle Scholar
  14. 14.
    Losi P, Briganti E, Errico C, Lisella A, Sanguinetti E, Chiellini F, Soldani G (2013) Fibrin-based scaffold incorporating VEGF- and bFGF-loaded nanoparticles stimulates wound healing in diabetic mice. Acta Biomater 9(8):7814–7821. CrossRefGoogle Scholar
  15. 15.
    Xie JL, Bian HN, Qi SH, Chen HD, Li HD, Xu YB, Li TZ, Liu XS, Liang HZ, Xin BR, Huan Y (2008) Basic fibroblast growth factor (bFGF) alleviates the scar of the rabbit ear model in wound healing. Wound Repair Regen 16(4):576–581. CrossRefGoogle Scholar
  16. 16.
    Ayvazyan A, Morimoto N, Kanda N, Takemoto S, Kawai K, Sakamoto Y, Taira T, Suzuki S (2011) Collagen-gelatin scaffold impregnated with bFGF accelerates palatal wound healing of palatal mucosa in dogs. J Surg Res 171(2):e247–e257. CrossRefGoogle Scholar
  17. 17.
    Huang YC, Yang YT (2016) Effect of basic fibroblast growth factor released from chitosan-fucoidan nanoparticles on neurite extension. J Tissue Eng Regen Med 10(5):418–427. CrossRefGoogle Scholar
  18. 18.
    Nimni ME (1997) Polypeptide growth factors: targeted delivery systems. Biomaterials 18(18):1201–1225CrossRefGoogle Scholar
  19. 19.
    Freeman I, Kedem A, Cohen S (2008) The effect of sulfation of alginate hydrogels on the specific binding and controlled release of heparin-binding proteins. Biomaterials 29(22):3260–3268. CrossRefGoogle Scholar
  20. 20.
    Schultz V, Suflita M, Liu X, Zhang X, Yu Y, Li L, Green DE, Xu Y, Zhang F, DeAngelis PL, Liu J, Linhardt RJ (2017) Heparan sulfate domains required for fibroblast growth factor 1 and 2 signaling through fibroblast growth factor receptor 1c. J Biol Chem 292(6):2495–2509. CrossRefGoogle Scholar
  21. 21.
    Wenk E, Murphy AR, Kaplan DL, Meinel L, Merkle HP, Uebersax L (2010) The use of sulfonated silk fibroin derivatives to control binding, delivery and potency of FGF-2 in tissue regeneration. Biomaterials 31(6):1403–1413. CrossRefGoogle Scholar
  22. 22.
    Casu B, Lindahl U (2001) Structure and biological interactions of heparin and heparan sulfate. Adv Carbohydr Chem Biochem 57:159–206CrossRefGoogle Scholar
  23. 23.
    Li YC, Ho IH, Ku CC, Zhong YQ, Hu YP, Chen ZG, Chen CY, Lin WC, Zulueta MM, Hung SC, Lin MG, Wang CC, Hsiao CD (2014) Interactions that influence the binding of synthetic heparan sulfate based disaccharides to fibroblast growth factor-2. ACS Chem Biol 9(8):1712–1717. CrossRefGoogle Scholar
  24. 24.
    Nagumo T, Iizima-Mizui N, Fujihara M, Himeno J, Komiyama K, Umezawa I (1988) Separation of sulfated, fucose-containing polysaccharides from the brown seaweed Sargassum Kjellmanianum and their heterogeneity and antitumor activity. Kitasato Arch Exp Med 61(1):59–67Google Scholar
  25. 25.
    Chizhov AO, Dell A, Morris HR, Haslam SM, McDowell RA, Shashkov AS, Nifant'ev NE, Khatuntseva EA, Usov AI (1999) A study of fucoidan from the brown seaweed Chorda Filum. Carbohydr Res 320(1–2):108–119CrossRefGoogle Scholar
  26. 26.
    Huang YC, Liu TJ (2012) Mobilization of mesenchymal stem cells by stromal cell-derived factor-1 released from chitosan/tripolyphosphate/fucoidan nanoparticles. Acta Biomater 8(3):1048–1056. CrossRefGoogle Scholar
  27. 27.
    Chen M, Song K, Rao N, Huang M, Huang Z, Cao Y (2011) Roles of exogenously regulated bFGF expression in angiogenesis and bone regeneration in rat calvarial defects. Int J Mol Med 27(4):545–553. Google Scholar
  28. 28.
    Kim BS, Park JY, Kang HJ, Kim HJ, Lee J (2014) Fucoidan/FGF-2 induces angiogenesis through JNK- and p38-mediated activation of AKT/MMP-2 signalling. Biochem Biophys Res Commun 450(4):1333–1338. CrossRefGoogle Scholar
  29. 29.
    Park JH, Choi SH, Park SJ, Lee YJ, Park JH, Song PH, Cho CM, Ku SK, Song CH (2017) Promoting wound healing using low molecular weight fucoidan in a full-thickness dermal excision rat model. Mar Drugs 15(4).
  30. 30.
    Dai M, Zheng X, Xu X, Kong X, Li X, Guo G, Luo F, Zhao X, Wei YQ, Qian Z (2009, 2009) Chitosan-alginate sponge: preparation and application in curcumin delivery for dermal wound healing in rat. J Biomed Biotechnol:595126.
  31. 31.
    Lai HL, Abu'Khalil A, Craig DQ (2003) The preparation and characterisation of drug-loaded alginate and chitosan sponges. Int J Pharm 251(1–2):175–181CrossRefGoogle Scholar
  32. 32.
    Wang J, Liu L, Zhang Q, Zhang Z, Qi H, Li P (2009) Synthesized oversulphated, acetylated and benzoylated derivatives of fucoidan extracted from Laminaria Japonica and their potential antioxidant activity in vitro. Food Chem 114(4):1285–1290. CrossRefGoogle Scholar
  33. 33.
    Terho TT, Hartiala K (1971) Method for determination of the sulfate content of glycosaminoglycans. Anal Biochem 41(2):471–476. CrossRefGoogle Scholar
  34. 34.
    Kusaykin M, Bakunina I, Sova V, Ermakova S, Kuznetsova T, Besednova N, Zaporozhets T, Zvyagintseva T (2008) Structure, biological activity, and enzymatic transformation of fucoidans from the brown seaweeds. Biotechnol J 3(7):904–915. CrossRefGoogle Scholar
  35. 35.
    Li B, Lu F, Wei X, Zhao R (2008) Fucoidan: structure and bioactivity. Molecules 13(8):1671–1695CrossRefGoogle Scholar
  36. 36.
    Ale MT, Mikkelsen JD, Meyer AS (2011) Important determinants for fucoidan bioactivity: a critical review of structure-function relations and extraction methods for fucose-containing sulfated polysaccharides from brown seaweeds. Mar Drugs 9(10):2106–2130. CrossRefGoogle Scholar
  37. 37.
    Matthaus B (2002) Antioxidant activity of extracts obtained from residues of different oilseeds. J Agric Food Chem 50(12):3444–3452CrossRefGoogle Scholar
  38. 38.
    Huang YC, Li RY (2014) Preparation and characterization of antioxidant nanoparticles composed of chitosan and fucoidan for antibiotics delivery. Mar Drugs 12(8):4379–4398. CrossRefGoogle Scholar
  39. 39.
    Palanisamy S, Vinosha M, Marudhupandi T, Rajasekar P, Prabhu NM (2017) Isolation of fucoidan from Sargassum Polycystum Brown algae: structural characterization, in vitro antioxidant and anticancer activity. Int J Biol Macromol 102:405–412. CrossRefGoogle Scholar
  40. 40.
    Machova E, Bystricky S (2013) Antioxidant capacities of mannans and glucans are related to their susceptibility of free radical degradation. Int J Biol Macromol 61:308–311. CrossRefGoogle Scholar
  41. 41.
    Tsiapali E, Whaley S, Kalbfleisch J, Ensley HE, Browder IW, Williams DL (2001) Glucans exhibit weak antioxidant activity, but stimulate macrophage free radical activity. Free Radic Biol Med 30(4):393–402CrossRefGoogle Scholar
  42. 42.
    Mak W, Hamid N, Liu T, Lu J, White WL (2013) Fucoidan from New Zealand Undaria pinnatifida: monthly variations and determination of antioxidant activities. Carbohydr Polym 95(1):606–614. CrossRefGoogle Scholar
  43. 43.
    Yan JK, Wang WQ, Ma HL, Wu JY (2012) Sulfation and enhanced antioxidant capacity of an exopolysaccharide produced by the medicinal fungus Cordyceps sinensis. Molecules 18(1):167–177. CrossRefGoogle Scholar
  44. 44.
    Tabata Y, Hijikata S, Ikada Y (1994) Enhanced vascularization and tissue granulation by basic fibroblast growth factor impregnated in gelatin hydrogels. J Control Release 31(2):189–199. CrossRefGoogle Scholar
  45. 45.
    Chabut D, Fischer AM, Colliec-Jouault S, Laurendeau I, Matou S, Le Bonniec B, Helley D (2003) Low molecular weight fucoidan and heparin enhance the basic fibroblast growth factor-induced tube formation of endothelial cells through heparan sulfate-dependent alpha6 overexpression. Mol Pharmacol 64(3):696–702. CrossRefGoogle Scholar
  46. 46.
    Ud-Din S, Bayat A (2016) Non-invasive objective devices for monitoring the inflammatory, proliferative and remodelling phases of cutaneous wound healing and skin scarring. Exp Dermatol 25(8):579–585. CrossRefGoogle Scholar
  47. 47.
    Kong Y, Xu R, Darabi MA, Zhong W, Luo G, Xing MM, Wu J (2016) Fast and safe fabrication of a free-standing chitosan/alginate nanomembrane to promote stem cell delivery and wound healing. Int J Nanomedicine 11:2543–2555. Google Scholar
  48. 48.
    Lin HY, Yeh CT (2010) Alginate-crosslinked chitosan scaffolds as pentoxifylline delivery carriers. J Mater Sci Mater Med 21(5):1611–1620. CrossRefGoogle Scholar
  49. 49.
    Zhang JD, Cousens LS, Barr PJ, Sprang SR (1991) Three-dimensional structure of human basic fibroblast growth factor, a structural homolog of interleukin 1 beta. Proc Natl Acad Sci U S A 88(8):3446–3450CrossRefGoogle Scholar
  50. 50.
    Kanazawa S, Fujiwara T, Matsuzaki S, Shingaki K, Taniguchi M, Miyata S, Tohyama M, Sakai Y, Yano K, Hosokawa K, Kubo T (2010) bFGF regulates PI3-kinase-Rac1-JNK pathway and promotes fibroblast migration in wound healing. PLoS One 5(8):e12228. CrossRefGoogle Scholar
  51. 51.
    Jastrebova N, Vanwildemeersch M, Lindahl U, Spillmann D (2010) Heparan sulfate domain organization and sulfation modulate FGF-induced cell signaling. J Biol Chem 285(35):26842–26851. CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media B.V., part of Springer Nature 2018

Authors and Affiliations

  1. 1.Department of Food Science, College of Life ScienceNational Taiwan Ocean UniversityKeelungTaiwan

Personalised recommendations